BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 22734451)

  • 1. Update on leukotriene receptor antagonists in preschool children wheezing disorders.
    Montella S; Maglione M; De Stefano S; Manna A; Di Giorgio A; Santamaria F
    Ital J Pediatr; 2012 Jun; 38():29. PubMed ID: 22734451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Montelukast in pediatric asthma management.
    Walia M; Lodha R; Kabra SK
    Indian J Pediatr; 2006 Apr; 73(4):275-82. PubMed ID: 16816486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukotriene receptor antagonists as maintenance and intermittent therapy for episodic viral wheeze in children.
    Brodlie M; Gupta A; Rodriguez-Martinez CE; Castro-Rodriguez JA; Ducharme FM; McKean MC
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD008202. PubMed ID: 26482324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daily inhaled corticosteroids or montelukast for preschoolers with asthma or recurrent wheezing: A systematic review.
    Castro-Rodriguez JA; Rodriguez-Martinez CE; Ducharme FM
    Pediatr Pulmonol; 2018 Dec; 53(12):1670-1677. PubMed ID: 30394700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should we use montelukast in wheezy children?
    Haq I; Harris C; Taylor J; McKean MC; Brodlie M
    Arch Dis Child; 2017 Nov; 102(11):997-998. PubMed ID: 28780506
    [No Abstract]   [Full Text] [Related]  

  • 6. Montelukast in childhood asthma: what is the evidence for its use?
    Amlani S; McIvor RA
    Expert Rev Respir Med; 2011 Feb; 5(1):17-25. PubMed ID: 21348582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.
    Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL
    Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cough, asthma, and cysteinyl-leukotrienes.
    Niimi A
    Pulm Pharmacol Ther; 2013 Oct; 26(5):514-9. PubMed ID: 23774534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukotriene receptor antagonists pranlukast and montelukast for treating asthma.
    Matsuse H; Kohno S
    Expert Opin Pharmacother; 2014 Feb; 15(3):353-63. PubMed ID: 24350802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukotriene modifiers in pediatric asthma management.
    Bisgaard H
    Pediatrics; 2001 Feb; 107(2):381-90. PubMed ID: 11158473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Montelukast in the treatment of mild to moderate persistent asthma].
    Bellecoste V; Devouassoux G; Pacheco Y
    Rev Mal Respir; 2011 Jun; 28(6):706-29. PubMed ID: 21742233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukotriene-receptor antagonists. Role in asthma management.
    D'Urzo AD; Chapman KR
    Can Fam Physician; 2000 Apr; 46():872-9. PubMed ID: 10790819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukotriene receptor antagonists--risks and benefits for use in paediatric asthma.
    Spahr JE; Krawiec ME
    Expert Opin Drug Saf; 2004 May; 3(3):173-85. PubMed ID: 15155146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy with a long-acting beta-agonist and a leukotriene antagonist in moderate asthma.
    Deykin A; Wechsler ME; Boushey HA; Chinchilli VM; Kunselman SJ; Craig TJ; DiMango E; Fahy JV; Kraft M; Leone F; Lazarus SC; Lemanske RF; Martin RJ; Pesola GR; Peters SP; Sorkness CA; Szefler SJ; Israel E;
    Am J Respir Crit Care Med; 2007 Feb; 175(3):228-34. PubMed ID: 16973987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermittent montelukast in children aged 10 months to 5 years with wheeze (WAIT trial): a multicentre, randomised, placebo-controlled trial.
    Nwokoro C; Pandya H; Turner S; Eldridge S; Griffiths CJ; Vulliamy T; Price D; Sanak M; Holloway JW; Brugha R; Koh L; Dickson I; Rutterford C; Grigg J
    Lancet Respir Med; 2014 Oct; 2(10):796-803. PubMed ID: 25212745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukotriene receptor antagonists for eczema.
    Ferguson L; Futamura M; Vakirlis E; Kojima R; Sasaki H; Roberts A; Mori R
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD011224. PubMed ID: 30343498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled corticosteroids or montelukast as the preferred primary long-term treatment for pediatric asthma?
    Jartti T
    Eur J Pediatr; 2008 Jul; 167(7):731-6. PubMed ID: 18214538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Montelukast in paediatric asthma: where we are now and what still needs to be done?
    Bush A
    Paediatr Respir Rev; 2015 Mar; 16(2):97-100. PubMed ID: 25499571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment options for initial maintenance therapy of persistent asthma: a review of inhaled corticosteroids and leukotriene receptor antagonists.
    Creticos PS
    Drugs; 2003; 63 Suppl 2():1-20. PubMed ID: 14984077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A meta-analysis of montelukast for recurrent wheeze in preschool children.
    Hussein HR; Gupta A; Broughton S; Ruiz G; Brathwaite N; Bossley CJ
    Eur J Pediatr; 2017 Jul; 176(7):963-969. PubMed ID: 28567533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.